Zscaler (ZS) Jumps After Topping Profit, Sale, and Outlook Estimates to Prompt an Upgrade to 'Outperform' at BMO

Go back to Zscaler (ZS) Jumps After Topping Profit, Sale, and Outlook Estimates to Prompt an Upgrade to 'Outperform' at BMO

Zscaler (ZS) Sees Intra-Day Strength

May 27, 2021 10:30 AM EDT

Zscaler (NASDAQ: ZS) sees intra-day strength. Shares up 0.7%. Shares saw a large gap yesterday following blow-out earnings.

... More

Zscaler (ZS) PT Lowered to $215 at Deutsche Bank

May 26, 2021 6:40 AM EDT

Deutsche Bank analyst Patrick Colville lowered the price target on Zscaler (NASDAQ: ZS) to $215.00 (from $233.00) while maintaining a Buy rating.... More

Zscaler (ZS) PT Raised to $215 at Mizuho Securities

May 26, 2021 6:34 AM EDT

Mizuho Securities analyst Gregg Moskowitz raised the price target on Zscaler (NASDAQ: ZS) to $215.00 (from $200.00) while maintaining a Buy rating.... More

UPDATE: BMO Capital Upgrades Zscaler (ZS) to Outperform

May 26, 2021 2:26 AM EDT

(Updated - May 26, 2021 4:40 AM EDT)

BMO Capital analyst Keith Bachman upgraded Zscaler (NASDAQ: ZS) from Market Perform to Outperform with a price target of $225.00 (from $202.00).

The analyst comments "We have stated on more than one occasion that ZS... More

After-Hours Stock Movers 05/25: (PIRS) (INSE) (ZS) Higher; (TVTX) (JWN) (PACK) Lower (more...)

May 25, 2021 5:57 PM EDT

After-Hours Stock Movers:

Pieris Pharma (NASDAQ: PIRS) 46% HIGHER; adds to 103% intra-day surge on a collaboration and license agreement with Genentech, which includes $20 million as an upfront payment and is eligible to receive more than $1.4 billion in additional potential milestone payments plus royalties.

Travere Therapeutics, Inc. (NASDAQ: TVTX) 10% LOWER; today provided a regulatory update for its sparsentan program in focal segmental glomerulosclerosis (FSGS). Following achievement of the interim proteinuria endpoint in the ongoing Phase 3 DUPLEX... More

Zscaler (ZS) Tops Q3 EPS by 8c, Offers Q4 Guidance

May 25, 2021 4:08 PM EDT

Zscaler (NASDAQ: ZS) reported Q3 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $176.4 million versus the consensus estimate of $163.71 million.

GUIDANCE:

Zscaler sees Q4 2021 EPS of $0.08-$0.09, versus the consensus of $0.09. Zscaler sees Q4... More

Zscaler (ZS) to Acquire Smokescreen Technologies

May 25, 2021 4:00 PM EDT

Zscaler, Inc. (NASDAQ: ZS) entered into a definitive agreement to acquire Smokescreen Technologies, a leader in active defense and deception technology. Smokescreen's cutting edge capabilities will be integrated into the Zscaler Zero Trust Exchange, further building upon Zscalers ability to precisely detect the most sophisticated, highly targeted attacks, ransomware, and lateral movement attempts. Additionally, Smokescreen will help provide rich threat... More